Metabolism of Angiotensin-(1-7) by Angiotensin-Converting Enzyme

Hypertension

Volumn 31, Issue 1, 1998, Pages 362-367

  Chappell, Mark C ^a   Pirro, Nancy T ^a   Sykes, Angela ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETIC ACID; ENALAPRILAT; LISINOPRIL; ANGIOTENSIN II; ANGIOTENSIN II (1 7); ANGIOTENSIN II (1-7); BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; PEPTIDE FRAGMENT;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CATALYSIS; CONTROLLED STUDY; DOG; DRUG EFFECT; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME SUBSTRATE; HYDROLYSIS; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; ANIMAL; CELL MEMBRANE; CHEMICAL MODEL; ENZYMOLOGY; HUMAN; KINETICS; LUNG; METABOLISM;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; CELL MEMBRANE; DOGS; HUMANS; KINETICS; LISINOPRIL; LUNG; MODELS, CHEMICAL; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A;

EID: 0031600505     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.362     Document Type: Article

References (42)

1. Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, Ferrario CM. Opposing actions of Angiotensin-(1-7) and Angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 1995;25:1260-1265.
2. DelliPizzi A, Hilchey SD, Bell-Quilley CP. Natriuretic actions of angiotensin-(1-7). Br J Pharmacol. 1994;111:1-3.
3. 2 release. Hypertension. 1995;25:1238-1244.
4. Handa RK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol. 1996;270:F141-F147.
5. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesenteric and hind-quarters vascular beds. Eur J Pharmacol. 1993;234:35-42.
6. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
7. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27:523-528.
8. Paula RD, Lima CV, Khosla MC, Santos RAS. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension. 1995;26:1154-1159.
9. Lawrence AC, Clark IJ, Campbell DJ. Increased angiotensin-(1-7) in hypophysial-portal plasma of conscious sheep Neuroendocrinology. 1992;55:105-114.
10. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension. 1991;18:763-773.
11. Kohara K, Brosnihan KB, Chappell MC, Khosla MC, Ferrario CM. Angiotensin-(1-7): A member of circulating angiotensin peptides. Hypertension. 1991;17:131-138.
12. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides. 1993;14:883-891.
13. Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens. 1996;14:799-805.
14. Iyer SN, Chappell MC, Averill DA, Diz DI, and Ferrario CM. Vasodepressor actions of Angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension (in press), 1998.
15. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neprilysin. Life Sci. 1993;52:1461-1480.
16. Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension. 1992;19:692-696.
17. Bull HG, Thornberry NA, Cordes EH. Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography. J Biol Chem. 1985;260:2903-2972.
18. Hooper NM, Turner AJ. Isolation of two differentially glycosylated forms of peptidyl-dipeptidase A (angiotensin converting enzyme) from pig brain: a re-evaluation of their role in neuropeptide metabolism. Biochem J. 1987;241:625-633.
19. Schullek JR, Wilson IB. Purification of bovine angiotensin converting enzyme. Life Sci. 1989;45:685-690.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
21. Wei L, Alhenc-Gelas F, Corvol P, Clauser E. The two homologous domains of human angiotensin I-converging enzyme are both catalytically active. J Biol Chem. 1991;266:9002-9008.
22. Hooper NM, Keen J, Pappin DJC, Turner AJ. Pig kidney angiotensin converting enzyme. Biochem. 1987;247:85-93.
23. Heukeshoven J. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis. 1985;6:103-112.
24. Chappell MC, Welches WR, Brosnihan KB, Ferrario CM. Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate. Peptides. 1992;13:943-946.
25. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain: evidence for differential processing of angiotensin peptides. J Biol Chem. 1989;264:16518-16523.
26. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. J Vasc Med Biol. 1994;5:129-137.
27. Sybertz EJ, Chin PJS, Vemulapalli S, Pitts B, Foster CJ, Watkins RW, Barnett A, Haslanger MF. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in deoxycorticosterone acetate-sodium hypertensive rats. J Pharmacol Exp Ther. 1989;250:624-631.
28. Friedman TC, Orlowski M, Wilk S. Prolyl endopeptidase: Inhibition in vivo by N-benzyloxycarbonyl-prolyl-prolinal. J Neurochem. 1984;42:237-241.
29. Skidgel RA, Tan F, Morris PW, Erdos EG. Cloning and sequencing of human renal angiotensinase C. Hypertension. 1993;21:540.
30. Bunning P, Kleemann SG, Riordan JF. Essential residues in angiotensin converting enzyme: modification with 1-Fluoro-2,4-dinitrobenzene. Biochemistry. 1990;29:10488-10492.
31. Riordan JF, Chen YN, Kleemann SG, Bunning P. Peptide inhibitors and the active site(s) of angiotensin converting enzyme. Biomed Biochim Acta. 1991;50:809-814.
32. Deddish PA, Wang LX, Jackman HL, Michel B, Wang J, Skidgel RA, Erdos EG. Single-angiotensin I-converting enzyme (kininase II). characterization and properties. J Pharmacol Exp Ther. 1996;279:1582-1589.
33. Jaspard E, Wei L, Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin-l-converting enzyme (Kininase II). J Biol Chem. 1993;268:9496-9503.
34. Ehlers, M. R. W, Riordan, J. F. Angiotensin-converting enzyme: biochemistry and molecular biology. In J. H. Laragh & B. M. Brenner (Eds.), Hypertension: Pathophysiology, Diagnosis, and Management. (pp. 1217-1231). New York: Raven Press, 1990.
35. 2 and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A. 1985;82:1025-1029.
36. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension (in press) 1998.
37. Wei L, Clauser E, Alhenc-Gelas F, Corvol P. The two homologous domains of human angiotensin-I-converting enzyme interact differently with competitive inhibitors. J Biol Chem. 1992;267:13398-13405.
38. Raousseau A, Michaud A, Chauvet M-T, Lenfant M, Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem. 1995;270:3656-3661.
39. Jaspard E, Alhenc-Gelas F. Catalytic properties of the two active sites of angiotensin I-converting enzyme on the cell surface. Biochem Biophys Res Commun. 1995;211:528-534.
40. Chen YN, Ehlers MRW, Riordan JF. The functional role of tyrosine-200 in human testis angiotensin-converting enzyme. Biochem Biophys Res Commun. 1992;184:306-309.
41. Deddish PA, Jackman HL, Wang HZ, Skidgel RA, Erdos EG. An N-domain specific substrate and C-domain specific inhibitor of angiotensin converting enzyme: Angiotensin-(1-7) and keto-ACE. Hypertension. 1997;30:P71 Abstract.
42. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29:394-400.